Alfasigma has taken another step in its transformation journey by adopting an Open Access publication policy, ensuring that all company-sponsored and funded research is accessible barrier-free to everyone, for the benefit of health care professionals, patients, caregivers, and the global scientific community.

Removing paywall barriers to knowledge

Open Access is not only about removing paywalls, it’s about accelerating growth, driving innovation, and fostering a shared culture of science.
It means helping scientists and health care professional to meet patients’ needs faster and turning ideas into tangible solutions.
It’s about making things happen, together: strengthening partnerships and collaboration among healthcare professionals, policymakers, and scientists worldwide.

Aligned with global best practices

By joining leading pharmaceutical innovators, Alfasigma positions itself among the few companies in the industry to adopt a comprehensive Open Access mandate.

Aligned with the principles celebrated during International Open Access Week (20–26 October 2025), this initiative reinforces Alfasigma’s values of transparency, collaboration, and responsibility.

The company will work closely with research partners, collaborators, and  authors to implement this mandate effectively, ensuring that every publication contributes to a more open, informed, and connected scientific community.